簡易檢索 / 詳目顯示

研究生: 郭怡萍
Kuo,Yi-Ping
論文名稱: 寡孢根黴菌與胚芽乳桿菌共發酵天貝緩解棕櫚酸誘導人類肝癌細胞HepG2及FL83B細胞脂毒性之研究
Alleviation of Rhizopus oligosporus and Lactobacillus plantarum co-fermented tempeh on palmitic acid-induced lipotoxicity in HepG2 and FL83B cells
指導教授: 吳明昌
Wu, Ming-Chang
學位類別: 碩士
Master
系所名稱: 農學院 - 食品科學系所
Department of Food Science
畢業學年度: 107
語文別: 中文
論文頁數: 61
中文關鍵詞: 天貝非酒精性脂肪肝棕櫚酸
外文關鍵詞: Tempeh, non-alcoholic fatty liver disease (NAFLD), palmitic acid (PA)
DOI URL: http://doi.org/10.6346/NPUST201900252
相關次數: 點閱:24下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統
  • 天貝是一種黃豆發酵產品,為印尼傳統發酵食物,主要是因為其具有多項有益的成份及抗氧化能力,天貝發酵之菌株主要為寡孢根黴菌,其屬於毛黴科家族之真菌。有研究發現,寡孢根黴菌與胚芽乳桿菌共同培養的天貝比未發酵大豆與寡孢根黴菌培養的天貝具有較高的營養和生物活性。天貝具有調節血糖和增強免疫力的活性,但糖尿病併發症和非酒精性脂肪肝的功效仍未得到闡明。因此,在本研究中,我們評估寡孢根黴菌與胚芽乳桿菌共同培養的天貝萃取異黃酮對棕櫚酸誘導的肝細胞脂質堆積和發炎反應以及脂肪生成之影響。在HepG2和FL83B細胞中使用棕櫚酸誘導脂質毒性24小時。接著使用未發酵的大豆、寡孢根黴菌培養的天貝和寡孢根黴菌與胚芽乳桿菌共同培養的天貝萃取其異黃酮,以不同的劑量來處理細胞24和48小時,以MTT試驗來測量細胞毒性。油紅染色用於測定細胞攝取的游離脂肪酸。此外,西方墨點法用於測定脂質代謝和脂肪生成以及發炎反應相關的各種標誌物的蛋白質表現。結果顯示來自寡孢根黴菌與胚芽乳桿菌共同培養的天貝萃取物異黃酮具有降低HepG2細胞存活率。此外,在所有的異黃酮萃取組別中皆能抑制棕櫚酸所誘導的HepG2和FL83B細胞內脂質堆積,另外,亦發現異黃酮萃取物能使棕櫚酸對TNF-α、NF-κB、COX-2和FASN表現具有影響。這些結果說明了從寡孢根黴菌與胚芽乳桿菌共同培養的天貝萃取的異黃酮能減低棕櫚酸誘導的HepG2和FL83B細胞中的脂毒性和脂肪生成。本研究也顯示,從天貝萃取的異黃酮具有治療非酒精性脂肪肝的潛力,值得做更進一步的研究。

    Tempeh, which is a fermented soybean product consumed widely in Indonesia has several beneficial characteristics and antioxidative activity. Rhizopus oligosporus, a fungus of Mucoraceae family is widely used as the starter of homemade tempeh. It has been shown that R. oligosporus and L. plantarum co-inoculated tempeh contained higher isoflavones and possessed high nutritional and bioactive properties than R. oligosporus inoculated tempeh and unfermented soybean. Tempeh has the activity of regulating blood sugar and boosting immunity, but the efficacy of diabetic complications and non-alcoholic fatty liver is still not elucidated. Therefore, in the present study, we attempt to evaluate the effects of isoflavones extract from tempeh co-inoculated with Rhizopus oligosporus and L. plantarum on palmitic-induced lipid accumulation, inflammation and lipogenesis in hepatocytes. HepG2 and FL83B cells were treated with palmitate for 24 hours to induce lipid toxicity. The cells were then treated with different doses of isoflavones extract from unfermented soybean, isoflavones extract from R. oligosporus inoculated tempeh and isoflavones extract from R. oligosporus and L. plantarum co-inoculated tempeh for 24 or 48 hours. MTT assay was used to measure the cytotoxicity. Oil Red O staining was used to determine the cellular uptake of free fatty acid. In addition, western blotting was used to determine the expression levels of various protein related to lipid metabolism, lipogenesis and inflammations. Isoflavones extract from L. plantarum co-inoculated tempeh, caused a reduction in HepG2 cell viability. Furthermore, isoflavones extract in all groups reversed the palmitate-induced intracellular lipid accumulation in HepG2 and FL83B cells. Moreover, isoflavones extract was also found to be reverted the palmitic acid effect on the expression of TNF-α, NF-κB, COX-2, and FASN. These results indicated that isoflavones extract from tempeh co-inoculated with Rhizopus oligosporus and L. plantarum attenuates PA-induced lipotoxicity and lipogenesis in HepG2 and FL83B cells. In conclusion, this study suggested that isoflavones extract from tempeh has a therapeutic potential for fatty liver disease and warrants further investigation.

    摘要 I
    ABSTRACT III
    謝誌 V
    目錄 VI
    圖表目錄 IX
    縮寫對照表 XI
    壹、 前言 1
    貳、 文獻回顧 3
    一、 天貝簡介 3
    二、 天貝的生理機能 4
    (一) 降低胰島素抵抗改善Ⅱ型糖尿病的影響 4
    (二) 抑制發炎反應 5
    (三) 抗氧化活性 5
    (四) 抗高血壓與高血脂 6
    (五) 調節腸道免疫系統 7
    (六) 酒精誘導的肝損傷具有保護作用 9
    三、 非酒精性脂肪肝 (NAFLD) 10
    (一) NAFLD中脂毒性誘導的脂質代謝變化 12
    (二) 棕櫚酸誘導NAFLD發病機制的關鍵信號分子 13
    四、 發炎相關因子影響 14
    五、 脂肪酸合成酶 (FASN) 14
    參、 材料與方法 15
    一、 實驗材料、菌株種類及細胞株種類 15
    (一) 實驗材料 15
    (二) 菌株種類 15
    (三) 細胞株種類 15
    二、 實驗架構流程 16
    三、 方法 18
    (一) 未發酵黃豆與天貝樣品製備 18
    (二) 樣品冷凍乾燥 18
    (三) 萃取樣品中異黃酮製備 18
    (四) 胚芽乳桿菌之培養與活化 18
    (五) 胚芽乳桿菌之保存 19
    (六) 胚芽乳桿菌之計數 19
    (七) 棕櫚酸 (Palmitic acid)配置 19
    (八) 細胞培養液 19
    (九) 細胞活化與培養 20
    (十) 細胞冷凍保存 20
    (十一) 細胞計數 20
    (十二) 細胞存活率分析 (MTT cell viability assay) 21
    (十三) 細胞蛋白質萃取 22
    (十四) 蛋白質定量 22
    (十五) 西方墨點法 (Western blot) 23
    (十六) 油紅O染色法 (Oil Red O) 24
    (十七) 4% paraformaldehyde配置 25
    (十八) 統計分析 25
    肆、 結果與討論 26
    (一) Palmitic acid (PA)對於HepG2和FL83B細胞存活率影響 26
    (二) 未發酵大豆與寡孢根黴菌發酵的天貝以及寡孢根黴菌與胚芽乳桿菌共同培養的天貝萃取其異黃酮,對於HepG2細胞 28
    (三) 未發酵大豆與寡孢根黴菌發酵的天貝以及寡孢根黴菌與胚芽乳桿菌共同培養的天貝萃取其異黃酮,對於FL83B細胞存活 30
    (四) Tempeh 抑制棕櫚酸誘導肝臟脂肪堆積作用 32
    (五) Tempeh 改善棕櫚酸誘導脂肪肝發炎表現 45
    (六) 在HepG2細胞中添加總異黃酮調降脂肪細胞凋亡蛋白表現 46
    伍、 結論 50
    陸、 文獻回顧 53
    作者介紹 61

    武氏清恒。(2016)。子孢根黴和植物乳桿菌共接種大豆天貝生活性成分之分離與鑑定。國立屏東科技大學。食品科學國際碩士學位學程碩士論文。
    Ahmad, A., Ramasamy, K., Majeed, A.B., and Mani, V. 2015. Enhancement of beta-secretase inhibition and antioxidant activities of tempeh, a fermented soybean cake through enrichment of bioactive aglycones. Pharmaceutical Biology. 53: 758–766.
    Ahmad, A., Ramasamy, K., Jaafar, S.M., Majeed, A.B., and Mani, V. 2014. Total isoflavones from soybean and tempeh reversed scopolamine-induced amnesia, improved cholinergic activities and reduced neuroinflammation in brain. Food and Chemical Toxicology. 65: 120–128.
    Astuti, M., Meliala, A., Dalais, F.S., and Wahlqvist, M.L.2000. Tempe, a nutritious and healthy food from Indonesia. Asian Pacific Journal of Clinical Nutrition. 9: 322–325.
    Ahmad, A.,Ramasamy, K.,Majeed, A. B., and Mani, V.2015. Enhancement of beta-secretase inhibition and antioxidant activities of tempeh, a fermented soybean cake through enrichment of bioactive aglycones. Pharm Biol. 53: 758-66.
    Buss, H., Dörrie, A., Schmitz, M.L., Hoffmann, E., Resch, K., and Kracht, M. 2004. Constitutive and interleukin-1-inducible phosphorylation of p65 NFκB at serine 536 is mediated by multiple protein kinases including IB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1(TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem. 279: 55633–55643.
    Babu, P.D ., Bhakyaraj, R ., and Vidhyalakshmi, R.2009. A low cost nutritional food “tempeh”- a review. World J Dairy Food Sci .4: 22-27.
    Cho, K.M., Lee, J.H., Yun, H.D., Ahn, B.Y., Kim, H., and Seo, W.T. 2011. Changes of phytochemical constituents (isoflavones, flavanols, and phenolic acids) during cheonggukjang soybeans fermentation using potential probiotics Bacillus subtilis CS90. Journal of Food Composition and Analysis. 24: 402-410.
    Chang, C., Hsu, C., Chou, S., Chen, Y., Huang, F., and Chung, Y. 2009. Effect of fermentation time on the antioxidant activities of tempeh prepared from fermented soybean using Rhizopus oligosporus. International Journal of Food Science & Technology. 44: 799-806.
    Chiu, H.C., Kovacs, A., Ford D.A., Hsu, F. F., Garcia, R., Herrero, P., Saffitz, J.E .,and Schaffer, J.E.2001.A novel mouse model of lipotoxic cardiomyopathy. Journal of Clinical Investigation .107: 813-822.
    Dong, Wang., Li-jun, Wang., Feng-xue, Zhu., Ji-ye, Zhu., Xiao, Dong. Chen., Lei, Zou., Masayoshi, Saito., and Li-te, Li.2008. In vitro and in vivo studies on the antioxidant activities of the aqueous extracts of Douchi (a traditional Chinese salt-fermented soybean food). Food Chemistry. 107: 1421-1428.
    Esaki, Hideo., Onozaki, Hiromichi., Kawakishi, Shunro., and Osawa, Toshihiko.1996. New Antioxidant Isolated from Tempeh. Food Chem. 44: 696-700.
    Elena, Buzzetti., Massimo, Pinzani., and Emmanuel, A. T. 2016. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism: Clinical and Experimental. 65: 1038-1048.
    Feng, X.M., Erikson, A.R., and Schnurer, J. 2005. Growth of lactic acid bacteria and Rhizopus oligosporus during barley tempeh fermentation. International Journal of Food Microbiology.104: 249– 256.
    Gomez-Lechon, M.J., Donato, M.T., Martinez-Romero, A., Jimenez, N., Castell, J.V., and O'Connor, J.E. 2007. A human hepatocellular in vitro model to investigate steatosis. Chemico-Biological Interactions. 165: 106–16.
    Grishko, V., Rachek, L., Musiyenko, S., Ledoux, S.P., and Wilson, G.L. 2005. Involvement of mtDNA damagein free fatty acid-induced apoptosis. Free Radical Biology & Medicine. 38: 755-762.
    Gomez-Lechon, M.J., Donato, M.T., Martinez-Romero, A., Jimene ,N., Castell, J.V., and O'Connor, J.E. 2007. A human hepatocellular in vitro model to investigate steatosis. Chemico-Biological Interactions. 165: 106-116.
    Hur, W., Kim, S. W., Lee, Y. K., Choi, J. E., Hong, S. W., Song, M. J., Bae, S. H., Park, T., Um, S. J., and Yoon, S. K. 2012. Oleuropein reduces free fatty acid-induced lipogenesis via lowered extracellular signal-regulated kinase activation in hepatocytes. Nutrition Research. 32: 778-786.
    Harmeet, Malhi., Steven, F. Bronk., Nathan, W Werneburg., and Gregory, J. Gores. 2006. Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis. Journal of Biological Chemistry. 281: 12093-12101.
    Hassan, K., Bhalla, V., El-Regal, M. E., and A-Kader, H. H. 2014. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World Journal of Gastroenterology. 20: 12082-12101.
    Huang, Y. C., Wu, B. H., Chu, Y. L., Chang, W. C., and Wu, M. C. 2018. Effects of Tempeh Fermentation with Lactobacillus plantarum and Rhizopus oligosporus on Streptozotocin-Induced Type II Diabetes Mellitus in Rats. Nutrients. 10:1143.
    Huang, Y., Wang, X., Wang, J., Wu, F., Sui, Y., Yang, L., and Wang, Z. 2013. Lactobacillus plantarum strains as potential probiotic cultures with cholesterol-lowering activity. Journal of Dairy Science . 96: 2746-2753.
    Haron, H., Ismail, A., Azlan, A., Shahar, S., and Peng, L.S. 2009. Daidzein and genestein contents in tempeh and selected soy products. Food Chemistry. 115: 1350-1356.
    Izumi, T., Piskula, M.K., Osawa, S., Obata, A., Tobe, K., Saito, M., Kataoka, S., Kubota, Y., Kikuchi, M. 2000. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. Journal of Nutrition. 130: 1695-1699.
    Joshi-Barve, S., Barve, S. S., Amancherla, K., Gobejishvili, L., Hill, D., Cave, M., Hote, P., and McClain, C. J. 2007. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Journal of Hepatology. 46: 823-830.
    Jeong, H. S., Cho, Y. H., Kim, K. H., Kim, Y., Kim, K. S., Na, Y. C., Park, J., Lee, I. S., Lee, J. H., and Jang, H. J. 2016. Anti-lipoapoptotic effects of Alisma orientalis extract on non-esterified fatty acid-induced HepG2 cells. BMC Complementary and Alternative Medicine. 16: 239.
    Judith, C. M. Wolkers-Rooijackers., Martha, F. Endika., and Eddy, J. Smid. 2018. Enhancing vitamin B12 in lupin tempeh by in situ fortification. LWT - Food Science and Technology. 96: 513-518.
    Jura, J., Wegrzyn, P., Korostynski, M., Guzik, K., Oczko-Wojciechowska, M., Jarzab, M., Kowalska, M., Piechota, M., Przewłocki, R., and Koj, A. 2008. Identiication of interleukin-1 and interleukin-6-responsive genes inhuman monocyte-derived macrophages using microarrays. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1779: 383-389.
    Lin, C. L., Huang, H. C., and Lin, J. K. 2007. Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. Journal of Lipid Research. 48: 2334-2343.
    Lonardo, A.,Nascimbeni, F.,Targher,G., Bernardi, M., Bonino, F., and Bugianesi, E. Casini, A., Gastaldelli, A., Marchesini, G., Marra, F., Miele, L., Morisco, F., Petta, S., Piscaglia, F., Svegliati-Baroni, G., Valenti, L., and Bellentani, S. 2017. AISF position paper on non-alcoholic fatty liver disease (NAFLD): updates and future directions. Digestive and Liver Disease. 49: 471-483.
    Lima-Cabello,E.,García-Mediavilla,M.V.,Miquilena-Colina,M.E.,Vargas-Castrillón, J.,Lozano-Rodríguez,T.,Fernández-Bermejo,M., Olcoz, J.L, González-Gallego, J., García-Monzón, C., and Sánchez-Campos, S. 2011. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clinical Science . 120: 239-250.
    Laura, Martinez-Gili., Carmen, Garcia-Ruiz., and Carlos, Fernandez-Checa. 2016. Fatty Liver Disease: A Crosstalk Between Lipid Species. EMJ Hepatology. 4: 76-83.
    Mohd-Yusof, Hamidah., Ali, Norlaily. Mohd., Yeap, Swee. Keong., Ho, Wan. Yong., Beh, Boon. Kee., Koh, Soo. Peng., Long, Kamariah., Abdul-Aziz, Suraini., and Alitheen, Noorjahan. Banu. 2013. Hepatoprotective Effect of Fermented Soybean (Nutrient Enriched Soybean Tempeh) against Alcohol-Induced Liver Damage in Mice. Evidence-Based Complementary and Alternative Medicine. 274274.
    Murata, K., Ikehata, H., and Miyamoto, T., 1967. Studies on the nutritional value of tempeh. Journal of Food Science. 32: 580–586.
    Murata, K., Miyamoto, T., Kokufu, E., and Sanke, Y., 1970. Studies on the nutritional value of tempeh. 3. Changes in biotin and folic acid contents during tempeh fermentation. Journal of vitaminology. 16: 281–284.
    Meric, Erikci. Ertunc and Gökhan, S. Hotamisligil. 2016. Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment. Journal of Lipid Research. 2099-2114.
    Nanji, A. A., Jokelainen, K., Rahemtulla, A., Miao, L., Fogt, F., Matsumoto, H., Tahan, S. R., and Su, G. L. 1999. Activation of nuclear factor B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology. 30: 934-943.
    Nout, M. J. and Kiers, J. L. 2005. Tempe fermentation, innovation and functionality: update into the third millenium. Journal of Applied Microbiology. 98: 789-805.
    Nakamichi, Watanabe., Yasushi, endo., Kenshiro, fujimoto., and Hideyuki, aoki. 2006. Tempeh-like Fermented Soybean (GABA-tempeh) Has an Effective Influence on Lipid Metabolism in Rats. Journal of Oleo Science . 55: 391-396.
    Nakajima, N., Nozaki, N., Ishihara, K., Ishikawa, A., and Tsuji, H. 2005. Analysis of isoflavone content in tempeh, a fermented soybean, and preparation of a new isoflavone-enriched tempeh. Journal of Bioscience and Bioengineering. 100: 685-687.
    Orci, L. A., Gariani, K., Oldani, G., Delaune,V., Morel, P., and Toso ,C. 2016. Exercise-based interventions for non-alcoholic fatty liver disease: a meta-analysis and meta-regression. Clin Gastroenterol Hepatol. 14:1398-1411.
    Panwar, H., Calderwood, D., Gillespie, A. L., Wylie, A. R., Graham, S. F., Grant, I.R., and Green, B. D. 2016. Identification of lactic acid bacteria strains modulating incretin hormone secretion and gene expression in enteroendocrine cells. Journal of Functional Foods . 23: 348-358.
    Sanyal, A. J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., and Clore, J. N. 2001. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 120: 1183-1192.
    Starzynska-Janiszewska, A., Stodolak, B., and Mickowska, B. 2014. Effect of controlled lactic acid fermentation on selected bioactive and nutritional parameters of tempeh obtained from unhulled common bean (Phaseolus vulgaris) seeds. Journal of the Science of Food and Agriculture. 94: 359-366.
    Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., and Flier, J.S. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation. 116: 3015-3025.
    Soni, S., and Dey, G. 2014. Perspectives on global fermented foods. British Food Journal. 116: 1767-1787.
    Susan, Soka., Antonius, Suwanto., Iman, Rusmana., Dondin, Sajuthi., Diah, Iskandriati., and Katharina, Jessica. 2015. Analysis of Intestinal Mucosal Immunoglobulin A in Sprague Dawley Rats Supplemented with Tempeh. Journal of Biosciences. 22: 48-52.
    Tuohy, K. M., Probert, H. M., Smejkal, C. W and Gibson, G. R. 2003. Using probiotics and prebiotics to improve gut health. Drug Discovery Today. 8: 692-700.
    Ullah, R., Rauf, N., Nabi, G., Ullah, H., Shen, Y., Zhou, Y. D and Fu, J. 2019. Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates. International Journal of Biological Sciences. 15: 265-276.
    Vernon, G., Baranova, A., and Younossi, Z. M. 2011. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics. 34 : 274-285.
    Wan, Y., Liu, L.Y., Hong, Z.F., and Peng, J. 2014. Ethanol extract of attenuates hepatic lipid accumulation via AMPK activation in human HepG2 cells. Experimental and Therapeutic Medicine. 8: 79-84.
    Wang, D., Wang, L. J., Zhu, F. X., Zhu, J.Y., Chen, X. D., and Zou, L. 2008. In vitro and in vivo studies on the antioxidant activities of the aqueous extracts of Douchi (a traditional Chinese salt-fermented soybean food). Food Chemistry. 107: 1421-1428.
    Xuemei, Wang., Jialin, Xia., and Changtao, Jiang. 2019. Role of gut microbiota in the development of non-alcoholic fatty liver disease. Liver Research. 3: 25-30.
    Yang, S., Wang, L., Yan, Q., Jiang, Z., and Li, L. 2009. Hydrolysis of soybean isoflavone glycosides by a thermostable β-glucosidase from Paecilomycesthermophila. Food Chemistry. 115:.1247-1252.
    Yamashita, R., Saito, T., Satoh, S., Aoki, K., Kaburagi, Y., and Sekihara, H. 2005. Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line HepG2. Endocrine Journal. 52: 727-733.
    Yamada, H., Kikuchi, S., Inui, T., Takahashi, H., and Kimura, K. 2014. Gentiolactone, a secoiridoid dilactone from Gentiana triflora, inhibits TNF-alpha, iNOS and Cox-2 mRNA expression and blocks NF-κB promoter activity in murine macrophages. PLOS One. 9: e113834.
    Yanaka, K., Takebayashi, J., Matsumoto, T., and Ishimi, Y. 2012. Determination of 15 isoflavone isomers in soy foods and supplements by high-performance liquid chromatography. Journal of Agricultural and Food Chemistry. 60: 4012-4016.

    無法下載圖示 校外公開
    2024/07/28
    QR CODE